首页> 美国卫生研究院文献>Oncotarget >MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis
【2h】

MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis

机译:胶质瘤恶性进展中的MicroRNA表达模式和预后的5-microRNA特征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

MicroRNAs (miRNAs) are directly involved in the progression in various cancers. To date, no systematic researches have been performed on the expression pattern of miRNA during progression from low grade gliomas to anaplastic gliomas or secondary glioblastomas and those prognostic miRNAs in anaplastic gliomas and secondary glioblastomas. In the present study, high-throughput microarrays were used to measure miRNA expression levels in 116 samples in the different progression stages of glioma. We found that miRNA expression pattern totally altered when low grade gliomas progressed to anaplastic gliomas or secondary glioblastomas. However, anaplastic gliomas and secondary glioblastomas have similar expression pattern in miRNA level. Furthermore, we developed a five-miRNA signature (two protective miRNAs-miR-767-5p, miR-105; three risky miRNAs: miR-584, miR-296-5p and miR-196a) that could identify patients with a high risk of unfavorable outcome in anaplastic gliomas regardless of histology type. It should be highlighted that the five-miRNA signature can also identify patients who had a high risk of unfavorable outcome in secondary and TCGA Proneural glioblastomas, but not Neural, Classical and Mesenchymal glioblastomas. Taken together, our results demonstrate that miRNA expression patterns in the malignant progression of gliomas and a novel prognostic classifier, the five-miRNA signature, serve as a prognostic marker for patient risk stratification in anaplastic gliomas, Secondary and Proneural glioblastomas.
机译:MicroRNA(miRNA)直接参与各种癌症的进展。迄今为止,从低度神经胶质瘤到间变性神经胶质瘤或继发性胶质母细胞瘤的进展过程中,miRNA的表达模式以及间变性神经胶质瘤和继发性胶质母细胞瘤中那些预后的miRNA尚未进行系统的研究。在本研究中,高通量微阵列用于测量神经胶质瘤不同进展阶段的116个样品中的miRNA表达水平。我们发现,当低级神经胶质瘤发展为间变性神经胶质瘤或继发性胶质母细胞瘤时,miRNA表达模式完全改变。然而,间变性神经胶质瘤和继发性胶质母细胞瘤在miRNA水平上具有相似的表达模式。此外,我们开发了五个miRNA签名(两个保护性miRNA-miR-767-5p,miR-105;三个危险的miRNA:miR-584,miR-296-5p和miR-196a)可以识别高危患者间变性胶质瘤的不良预后,无论组织学类型如何。应当强调的是,五个miRNA标记还可以识别出继发性和TCGA前神经胶质母细胞瘤中不良转归高风险的患者,而不是神经,经典和间质性神经胶质母细胞瘤。两者合计,我们的结果表明,在神经胶质瘤恶性进展中的miRNA表达模式和一种新的预后分类器,即5-miRNA标志,可作为间变性神经胶质瘤,继发性和前神经胶质母细胞瘤患者风险分层的预后标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号